2021-04-13

Cranial Fixation and Stabilization Market Demand | Trends| Research Report and Forecast

Market Overview

The Global Cranial Fixation and Stabilization Market is expected to reach USD 2.29 Billion by 2025, registering a CAGR of 8.90%.

This market growth can be attributed to the growing healthcare market and the ever-expanding technology market. Advances in these fields have created an environment that is conducive to the development of specialized surgical procedures for traditionally high-risk surgeries.

According to the UN, globally, one in six individuals suffers from a neurological disorder. There are several invasive surgeries that being developed to treat such conditions, requiring cranial fixation and stabilization equipment.

SEGMENTATION

By Category

Cranial stabilization equipment is used to secure the head during surgery, while cranial fixation implements are tools required to maintain the structural stability of the head and neck.

Cranial Fixation Systems: Cranial fixation covers a wide array of tools and implements such as meshes, flap tube clamps, plates, and screws to be used during surgery. They are used predominantly for affixing bones, securing skin, and enhancing cranial integrity post-surgeries such as craniotomies.

Cranial Stabilization Systems: Cranial surgeries are usually very delicate and complex, necessitating the use of equipment to immobilize the head. This is accomplished by the use of cranial stabilization equipment such as skull clamps and horseshoe headrests.

Get Free Sample @https://www.marketresearchfuture.com/sample_request/8163

By Product

Meshes: The leading market segment as 48% of all cranial injuries are maxillofacial. Over 52% of road accident-related injuries are mandibular fractures that require meshes.

Skull Clamps: Ideal for prolonged surgeries that require patient immobilization for long periods with limited soft tissue damage. Used to hold the head firmly in place during surgery.

Flap Tube Clamps: Used to attach cranial bones to the cranium during delicate surgeries when only a singular motion can be performed upon the afflicted area.

Horseshoe Headrests: Used in cases where head movement is not to be completely restrained and soft tissue damage needs to be minimized.

Plates: Used to seal gaping cranial wounds.

Screws: Facilitate the attachment of cranial bones.

Accessories: Include patient positioning systems and support systems.

By Type

Resorbable: Materials that are eventually broken down by the body. The growth of the segment is limited by the high costs of the equipment.

Non-Resorbable: These are biocompatible and offer unparalleled rigidity and stability to the cranium. Used extensively in developing countries due to their low costs.

By End User

Hospitals: The segment commands the largest share of the global cranial fixation and stabilization market as most cranial surgeries are performed in hospitals. Cranial surgeries require the latest equipment and amenities, along with a high level of expertise, which are offered by hospitals.

Ambulatory Surgical Centers: As emergency and temporary patient-stabilization surgeries are performed at these centers, the segment accounts for a small market share, which is somewhat offset by the higher revenue per surgery generated.

Others: This segment includes on-site trauma and emergency surgeries. This is a niche segment with growth potential due to the establishment of trauma centers at industrial complexes.

By Region

Americas: Largest regional market, with North America accounting for 55% of the global market share.

Asia-Pacific: Fastest growing regional market

Europe: Second-largest market

Middle East & Africa

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/cranial-fixation-stabilization-market-8163

Key Players

Johnson & Johnson (US)

Stryker (US)

Ostomed (UK)

KLS Martin Group (Germany)

Medtronic (US)

Integra LifeSciences Corporation (US)

Braun Melsungen AG (Germany)

Changzhou Huida (China)

DePuy Synthes (US)

Evonos (Germany)

Jeil Medical (South Korea)

Medicon (Germany)

Micromar (Brazil)

NEOS Surgery (Spain)

Pro Med Instruments (Germany)

Zimmer Biomet (US)

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

2021-04-12

Elastography Imaging Market Trends, Demand, Analysis Size, Forecast to 2027

Elastography Imaging Market Analysis

The global elastography imaging market is estimated to grow at an 11.1% CAGR between 2019-2025, reveals the new Market Research Future (MRFR) report. Elastography, simply put, is a medical imaging mode that maps the stiffness & elastic properties of soft tissue. Owing to its magnificent features, elastography imaging has wide applications in orthopedic and musculoskeletal applications, vascular, urology, obstetrics/gynecology, cardiology, radiology/general imaging, and others.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8070

Numerous factors are adding to the global elastography imaging market growth. Such factors, according to the recent MRFR report, include the growing demand for effective therapies for treating complicated disorders, changes in regulatory policies, increasing incidence of life-threatening diseases, and burgeoning demand for procedures that are minimally invasive to diagnose as well as treat various chronic diseases.

On the contrary, the high price of systems may limit the global elastography imaging market growth over the forecast period.

Regional Analysis

By region, the global elastography imaging market report covers the growth opportunities and recent trends across Europe, the Americas, the Middle East & Africa (MEA), and the Asia Pacific (APAC). Of these, the Americas will have the lions share in the market over the forecast period. Factors adding to the global elastography imaging market growth in the region include the increasing use of new technology, rising per capita healthcare expenditure, and increasing expenditure by healthcare bodies in research. Canada and the United States are the key contributors in the region for improving reimbursement scenario and a rise in insurance coverage.

The global elastography imaging market in Europe is predicted to hold the second-largest share over the forecast period for the involvement of top companies, rise in chronic diseases, and the presence of an established healthcare system.

The global elastography imaging market in the APAC region will have steady growth over the forecast period for the favorable initiatives undertaken by the government for healthcare reforms and the rising prevalence of chronic diseases. Meanwhile, a fall in capital investment may hinder the market growth.

The global elastography imaging market in the MEA will have a small share during the forecast period for the region’s low disposable income and limited access to medical treatment facilities.

Market Segmentation

The MRFR report provides an inclusive segmental analysis of the global elastography imaging market based on end user, application, and modality.

By modality, the elastography imaging market is segmented into magnetic resonance elastography (MRI) and ultrasound. Of these, the ultrasound segment will lead the market over the forecast period for the plentiful benefits that it offers. Meanwhile, magnetic resonance elastography will grow at the fastest pace for its increasing adoption rate and wider availability.

By application, the elastography imaging market is segmented into orthopedic and musculoskeletal applications, vascular, urology, obstetrics/gynecology, cardiology, radiology/general imaging, and others. Of these, radiology/general imaging will dominate the market over the forecast period for the rising prevalence of chronic diseases worldwide. Meanwhile, the cardiology segment will grow at the fastest pace over the forecast period for the increase in the patient population.

By end user, the elastography imaging market is segmented into research laboratories, diagnostic centers, hospitals and ambulatory surgical centers, and others. Of these, hospitals and ambulatory surgical centers will have a major share in the market over the forecast period. Rising number of hospitals coupled with the increasing number of hospitalizations are adding market growth. Meanwhile, the diagnostic centers will grow at the fastest pace over the forecast period for inclination towards these centers and increased patient preference.

Key Players

Leading players profiled in the global elastography imaging market report include General Electric Company, Supersonic Imagine, Samsung Electronics (Samsung Medison), Koninklijke Philips N.V., Mindray Medical International Ltd., Resoundant Inc., Hitachi Ltd., Esaote, Fujifilm Holdings Corporation, Siemens AG, and Canon Medical Systems Corporation.

Industry News

November 2019: SimonMed Imaging is the first to provide advanced screening for fatty liver disease. The VIDA 3T MRI helps to detect fibrosis resulting from fatty liver disease or other chronic liver diseases. It uses MRE (magnetic resonance elastography) that combines sound waves with MRI to develop an elastogram (visual map) to show the stiffness of the body tissue, thus offering radiologists with color contrasted clear visual, maximizing accuracy, and limiting error.

Browse Complete Report With Toc@ https://www.marketresearchfuture.com/reports/elastography-imaging-market-8070

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

2021-04-12

Augmented Reality in Healthcare Market Growth Opportunities, Investments, Key Players, COVID-19 Impact, Demand Analysis, Industry Size, Share and Trends

Augmented Reality in Healthcare Market Analysis

Global augmented reality in healthcare market is anticipated to expand at a whopping 23% CAGR over the assessment period (2017-2023). Augmented reality has gained immense prominence amid medical personnel for different applications including rehabilitation, minimally-invasive surgery and surgical preparation assessment. It has worked wonders in transforming the medical device sector and medicine simultaneously. This is basically a concept where real life elements are enhanced through additional visual information post recognizing the environment for guiding the augmentation which is, positioning and orientating the augmented content. Patients and doctors can use connected gadgets such as a tablet or a smartphone for leveraging this technology and adding valuable data in their treatment and the strides that are made in connected glasses and lenses will make this information access more seamless in the upcoming years. Augmented reality for patients can improve the treatment quality significantly that they get from the healthcare provider. Its key applications in the healthcare domain include fitness management, conducting complex surgeries, pharmacy benefit management, medical training, care management and patient education.

There are myriads of factors that is propelling the augmented reality in healthcare market growth. The different market factors and trends in this market according to an analysis conducted by MRFR (Market Research Future) include advancement in technology, growing need for virtual reality in healthcare, rising workload of healthcare experts, rising regulatory compliance for proper use of augmented reality in the healthcare domain, increasing healthcare expenditure, rising penetration of connected devices, and innovations in medical diagnostics. On the contrary, data security concern and high cost of augmented reality may restrict the demand of the augmented reality in healthcare market during the assessment period.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5236

Augmented Reality in Healthcare Market Key Players

Key players profiled in the augmented reality in healthcare market include Virtually Better (U.S.), Magic Leap, Inc. (U.S.), VirtaMed (Switzerland), Osterhout Design Group (U.S.), HTC (Taiwan), Siemens Healthineers (Germany), Blippar (U.K), Philips Healthcare (Netherlands & U.S.), CAE Healthcare (U.S.), Google LLC. (U.S.), Oculus VR (U.S.), Augmedix (U.S.), 3D Systems (U.S.), Medical Realities (U.K), Atheer (U.S.), Wikitude GmbH (Austria), Mindmaze (Switzerland), DAQRI (U.S.), and Microsoft Corporation (U.S.).

Sept 2018 - Researchers at Purdue University have adopted a new method which allows qualified physicians and surgeons across the world in assisting doctors that are less experienced in rural areas, war zones and natural disasters to perform complicated procedures.

Augmented Reality in Healthcare Market Segmentation

The MRFR report provides an all-inclusive segmental analysis of the augmented reality in healthcare market on the basis of device type, component and application.

Based on component, it is segmented into software, hardware and others. The hardware is further segmented into cameras, position tracker, projectors, displays, sensors and others.

Based on device type, the augmented reality in healthcare market is segmented into handheld device, head mounted display and others.

Based on application, it is segmented into education, medical training, fitness management and others.

Augmented Reality in Healthcare Market Regional Analysis

Based on region, the augmented reality in healthcare market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Rest of the World. Of these, North America will remain the foremost region in the market due to the rising use of consumer electronic devices that is fueling the growth of the market considerably. This market in Europe is expected to see a rapid growth during the forecast period. On the other hand, the Asia Pacific nations especially India, Japan and China are emerging markets that is expected to expand at a notable CAGR over the assessment period.

Augmented Reality in Healthcare Market Competitive Analysis

Enrichment in services and products is the key factor that is driving the productivity of the market and also controlling the trends which are gaining distinction in the augmented reality in healthcare market. The gaps present in the market are filled owing to the proper execution of supply chain strategies. Here the predilections of the players and the key success factors are growing consistently by the strategies that are used by the market contenders. The augmented reality in healthcare market’s progress rests in the drivers which are changing the market backdrop radically. The growth is modified in tandem as per the preference of the customer to attain utmost growth along with profitability in the future. Moreover, the launch of new services and products will add an extra impetus in the progress of the market. The growth plans have stimulated this market for prospective new entrants.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/augmented-reality-in-healthcare-market-5236

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

2021-04-12

Biosimilars Market Size 2021 Share, Growth, COVID-19 Impact Analysis, Business Opportunities | MRFR

Market Scope

Market Research Future (MRFR) expects the biosimilars market to thrive at a rate of 7.5% from 2020 to 2027 (analysis period).

Major Drivers and Impediments

Overall healthcare costs are rising owing to the high-priced pharmaceutical drugs, particularly biologics. Government bodies worldwide are concentrating on lower-priced drug synthesis. The United States spends the most on healthcare and is therefore, working on cutting down on the same. Likewise, price regulations in India and Japan for reducing the health budget have bolstered the demand for cost containment. This scenario has thrown light on the requirement for new affordable and effective therapeutics, which can be favorable for the biosimilars industry in subsequent years.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/1329

Popular biological drugs are edging towards patent cliff and this can mean substantial profits for the global market. Cost effectiveness of biosimilars, especially compared to the patented biologics and successful outcomes during clinical trials should also benefit the global market. The expanding pharmaceutical sector focused on developing biosimilar drugs can be another key growth booster in the near future.

Market Segmentation

Biosimilars industry can be considered with respect to product, applications, and end users.

The products based on which the market has been split into are recombinant glycosylated proteins, recombinant peptides, and recombinant non-glycosylated proteins. Recombinant non-glycosylated proteins are the biggest segment in the global market, thanks to the soaring cases of chronic disorders ranging from growth hormone deficiency to diabetes. As a result, recombinant non-glycosylated proteins are therapeutically used as they are readily available and are cost-effective.

Application-wise, the biosimilars market caters to chronic diseases, oncology, blood disorders, autoimmune diseases, infectious diseases, growth hormone deficiency, and more. Blood disorders have emerged as the top segment, as a result of the rising burden of the condition worldwide and the increased use of biosimilars by virtue of their low cost and the overall reduction in the treatment cost.

Major end users in the global market are hospitals and clinics as well as research institutes. Hospital and clinics are healthcare settings where treatment options and skilled professionals are easily available, and therefore, have emerged as the leading segment in the global industry.

Regional Status

Europe, MEA or Middle East & Africa along with the Americas, APAC or Asia Pacific are the primary markets for biosimilars.

Europe has taken the lead in the global market, as the region houses a vast elderly pool, with close to one fifth of the overall EU population aged more than 65 years. This has given way to several lifestyle-related disorders such as oncology, autoimmune diseases, diabetes, to name a few. Presumably, the scenario has raised the demand for biosimilars and can mean higher market growth over the next few years. In addition to this, numerous blockbuster biologics are on track to lose patent in the coming years, which should present lucrative opportunities to the biosimilar manufacturers.

The North American market displays a bright outlook and can emerge quite lucrative in the coming years, in view of the surging burden of chronic ailments in Canada and the United States. The rising spending on research activities by the healthcare agencies also fuels the market expansion in the region. Favorable reimbursement landscape in the region, especially in the US, encourages healthy competition as it results in lower incentives for the players to compete based on price.

The APAC market is slated to witness considerable growth, with China, South Korea and India offering a host of lucrative opportunities for drug development as well as commercialization. These are generics-driven countries and are known for frequently launching new and advanced manufacturing platforms, which has brought down the costs associated with biosimilar production. In the coming few years, majority of the patent expiries is touted to be in biosimilars, which is deemed as a profitable aspect by leading manufacturers and can translate into substantial market growth.

Eminent Vendors

Top manufacturers of biosimilars in the global industry include Stada Arzneimittel AG (Germany), Teva Pharmaceuticals (Israel), Biocon (India), Pfizer (US), Sandoz International (Germany), Eli Lily & Company (US), Actavis, Inc. (US), Dr. Reddy’s Laboratories (India), Cipla Ltd (India), Amgen, Inc. (US), Samsung Biologics (South Korea), Hospira Inc.(US), Mylan, Inc.(US), Celltrion (South Korea), to mention a few.

Latest Developments

March 2021

European Medicines Agency has given the green light to Kixelle, a biosimilar developed by Biocon Biologics Ltd., touted to be the fourth ever biosimilar insulin and the second fast-acting insulin analogue biosimilar to be introduced in the EU. Kixelle is a fast-acting biosimilar insulin analog that helps treat diabetes mellitus in adolescents, children and adults.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

2021-04-10

Clinical Reference Laboratory Market 2021 | Key Findings, COVID – 19 Impact Analysis, Business Trends, Industry Segments, Regional Study, Emerging Technologies and Future Prospects 2027

Market Synopsis

The global clinical reference laboratories market is considered to demonstrate 5.8% CAGR during the forecast period (2016-2027) owing to the usage of advanced robotics technology in reference laboratories, asserts Market Research Future (MRFR). Reference laboratories are referred to as commercial as well as private facilities which perform high-volume and specialty testing routinely. Physicians’ clinics, offices, government agencies, hospitals, pharmaceuticals, insurance companies, and biotechnology companies generally outsource the specialty to reference laboratories.

Free Sample Copy With Considering Coivd19 Impact on this Market @https://www.marketresearchfuture.com/sample_request/1190

Drivers and Constraints Impacting the Market

The global clinical reference laboratories market is progressively growing and is estimated to continue its growth in the coming years. With adoption of value-based services gaining prominence, hospitals are outsourcing some part or even all of their radiology and pathology diagnostic services. One of the major reasons for rising outsourcing by the hospitals is the constrained budgets due to Medicare reimbursements. The cut down in the rates of clinical laboratories reimbursements under Medicare has impacted the U.S. lab industry.

The U.S. clinical labs which depend on Medicare for 20% of their billings and for certain communities it is 80% of the business, got affected. To protect the hospitals, CEOs are outsourcing value-based services. Such factors have augmented the market for these independent reference laboratory services. Moreover, technologies which are capable of performing repetitive activities at high speed has developed to improve the consistency, quality, and effectiveness. The test results on samples which used to consume several hours to process can be found in a few minutes. Automation has impacted histopathology and microbiology to a great extent. Development of molecular technologies and genetics into the mainstream medicine being the most significant innovation, has impacted the health of the population, management of patients, and clinical practice. Moreover, launch of cost-effective, time-saving, and new diagnostic procedures owing to the accelerating number of FDA approvals is considered to contribute to the market growth.

On the flip side, illegible and incorrect sample labelling are some of the major factors considered to slowdown the market growth during the appraisal period.

Global Clinical Reference Laboratories Market: Segmental Analysis

The global clinical reference laboratories market has been segmented on the basis of service providers and application.

By mode of service providers, the global clinical reference laboratories market has been segmented into hospital based, stand alone, and clinical based. Among these, the stand-alone service providers are presumed to dominate the global market. With rising opportunities, presence of a new-range of condition-specific markers, availability of advanced technologies, and tests with advances in proteomics and genomics are some of the key factors likely to drive the segment.

By mode of application, the global clinical reference laboratories market has been segmented into clinical trials, laboratory medicine, and others.

Regional Insights

Geographically, the clinical reference laboratories market spans across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.

Among all the regions, America is considered to be the largest market for clinical reference laboratories. North America with countries such as Canada, and the United States lead the global market.

The European region occupies the second-largest share of the global market and is anticipated to continue its dominance in the coming years. The growth is credited to the increasing geriatric population, rising private and public funding for clinical laboratory test research, and growing incidences of chronic diseases. On the other hand, Asia Pacific is anticipated to expand at the fastest rate during the assessment period.

Industry Updates

January 18, 2019: One of the leading healthcare bio-analytic solution providers, Invitrocue has recently announced its first laboratory agreement in Germany in order to make its Onco-PDO personalized cancer screening service which will be available to the physicians and patients in Germany.

Competitive Dashboard

The prominent players operating the global clinical reference laboratories market are Quest Diagnostics, Clinical Reference Laboratory, ARUP Laboratories, Sonic HealthCare Limited, Unilabs, Laboratory Corporation of America, Bioreference Laboratories, KingMed Diagnostics, Aurora Diagnostics, Synlab International GmbH, and others.

Click here to get the short-term and long-term impact of COVID-19 on this Market: https://www.marketresearchfuture.com/reports/clinical-reference-laboratories-market-1190

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

2021-04-10

Medical Imaging Market: Key Player profile, Size, Share, Growth, Trends, Demand, Industry Analysis and Regional Outlook by 2027

Market Highlights

Market Research Future (MRFR) assessed the global medical imaging market 2020 through the review period till 2025. MRFR study states that the medical imaging market is expected to rise at 6.52% CAGR across the forecast period. By 2025, the medical imaging market value can touch USD 45,719.65 Mn. Technological advancements in healthcare applications and strategic agreements among top-notch tech companies and medical service providing giants are causes that are expected to support expansion of the medical imaging market in the years ahead. Improvements in point-of-care in case of ultrasound systems, easy portability of magnetoencephalography (MEG) brain scanners, and other revolutionizing trends in the diagnostic sector are anticipated to contribute to the improving impetus of the medical imaging market. Medical imaging solution providers are investing in innovations designed to offer accurate imaging solutions at affordable price. This is expected to create lucrative scope for the new players in the medical imaging market. However, surge in cost of diagnostic image solutions and inability of healthcare organizations to purchase expensive imaging systems due to economic disruption induced by COVID 19 pandemic can hinder the medical imaging market rise.

Segment Analysis

The segment study of the global medical imaging market are modality, end-user, and application. The modality-based segments of the medical imaging market are magnetic resonance imaging (MRI), x-ray systems, ultrasound systems, and nuclear imaging, and computed tomography (CT). The application-based segments of the global medical imaging market are cardiology, neurology, and oncology among others. The end-user-based segments of the medical imaging market are hospitals and clinics, academic institutes, diagnostic centers, and research organizations.

Imaging systems play pivotal role in diagnosis, and subsequent designing of correct and effective prognosis regimen. The increasing need for medical imaging systems in diagnosis, choice of treatment, and monitoring progress, is resulting in strategic joint ventures between reputed players to generate decent revenue. In addition, hike in research and development undertakings for advancements in imaging devices and growing awareness about new diagnostics solutions to detect fatal disease at early stage are creating scopes for emerging players to capitalize, for generating decent resources. Lack of trained professionals and financial strap on healthcare organizations are some issues hindering sales of medical imaging systems.

Regional Analysis

The Americas, Europe, Middle East and Africa, and Asia-Pacific are regions that are assessed under the geographic analysis of the medical imaging market. As per MRFR study, the Americas medical imaging market can dominant the global market in review tenure. The presence of numerous medical imaging system suppliers and growing prevalence of chronic diseases can prompt the regional market in the review period. The surge in funding by medical and technical organizations for research can benefit the market in the coming period. The rise in number of diagnostic tests and increase in research undertaking on cancer can bolster the regional medical imaging market growth.

In Europe, the medical imaging market is expected to earn decent value through the forecast term due to the presence of different favorable government laws and initiatives. The existence of a large population base suffering from lifestyle-associated conditions, and high rate of adoption imaging devices are other causes that can influence Europe medical imaging market in the approaching years.

In Asia Pacific, the medical imaging market can expand at high CAGR across the study tenure 2019 to 2025. Increase in capita health spending, developing healthcare sector across India, and Australia, growing older population base, and the presence a robust regulatory framework that aid in accelerated diagnostic process and product approvals at comparatively lower prices are some of the crucial factors that are identified to support APAC medical imaging market by 2025.

In the Middle East and Africa, the medical imaging market can rise at a modest pace from 2019 to 2025. The medical imaging market in Middle East can hold considerable market share through the assessment period. The developing medical infrastructure and surge in cases of medical tourism are causes that can earn profit for the medical device industry.

Key Players

Market Research Future (MRFR) recognizes some of the top-notch players in the medical imaging market. They are; Esaote S.p.A (Italy), Koninklijke Philips N.V. (Netherlands), Hitachi Ltd (Japan), FUJIFILM Holdings Corporation (Japan), Medtronic PLC (Ireland), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Analogic Corporation (US), Koninklijke Philips N.V., Siemens AG (Germany), Hologic, Inc. (US), Samsung (South Korea), Shimadzu Corporation (Japan), Carestream Health (US), CMR Naviscan (US), Canon Medical Systems Corporation (Japan), and General Electric Company (US),

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312

2021-04-09

Hormonal Implants Market Insights, Growth and Applications Till 2027

Market Highlights

The Global Hormonal Implants Market is estimated to have a positive growth at the CAGR of ~5.0% during the forecast period of 2019–2025.

A study observed that no pregnancy was observed in a group of certain women using hormonal implants for five years. Safety from unwanted pregnancies and suitable government programmers are the major factors driving the market growth.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/8242

However, cases of side-effects related to hormonal contraceptives, pricing variations, and limited availability of the product are restraining the growth of the market during the assessment period is hindering the growth of the global hormonal implants market in the forecast period.

Global, as well as local players, are present in the hormonal implants market. A majority of the market is currently held by global players like Allergan. In May 2016, ALLERGAN took an initiative to help the US military servicewomen to access LILETTA under the Federal Supply Schedule (FSS) price of USD 55.83 to educate these servicewomen about the importance of contraception.

Regional Analysis

The global hormonal implants market, by region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The hormonal implants market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European hormonal implants market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been segmented as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hormonal implants market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hormonal implants market in the Middle East & Africa has been divided into the Middle East and Africa.

Key Players

Some of the key players in the global hormonal implants market are Shanghai Dahua Pharmaceuticals Co., Merck & Co., Inc., Bayer HealthCare, Ltd and Allergan.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/hormonal-implants-market-8242

Segmental Analysis

The global hormonal implants market has been segmented based hormone, type, distribution sector, end user, and region.

The market, based on hormone, has been bifurcated into levonorgestrel and etonogestrel. The levonorgestrel segment is anticipated to hold the largest share in the market, market due to the wider preferability and longer durability compared to other contraceptives for the use of hormonal implants.

The market, based on the distribution sector, has been segmented into the public sector and private sector. The public sector market is expected to hold the largest share in the market, due to increasing adoption rates in public healthcare facilities under various government regulations.

The market, by end-user, has been divided into hospitals & clinics, academic & research institutes. The hospitals & clinics segment is expected to lead the market, due to the major commercialization is done through them.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.